Pharmacogenetics of KCNQ channel activation in 2 potassium channelopathy mouse models of epilepsy.

Vanhoof-Villalba, Stephanie L

Pharmacogenetics of KCNQ channel activation in 2 potassium channelopathy mouse models of epilepsy. [electronic resource] - Epilepsia 02 2018 - 358-368 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1528-1167

10.1111/epi.13978 doi


Animals
Anticonvulsants--pharmacology
Atrioventricular Block
Behavior, Animal
Bradycardia
Carbamates--pharmacology
Channelopathies
Death, Sudden
Disease Models, Animal
Drug Resistance
Drug Resistant Epilepsy--drug therapy
Electroencephalography
Epilepsy--drug therapy
Gene Expression Profiling
Heart Rate--drug effects
KCNQ Potassium Channels--agonists
KCNQ1 Potassium Channel--genetics
KCNQ2 Potassium Channel--genetics
KCNQ3 Potassium Channel--genetics
Kv1.1 Potassium Channel--genetics
Mice
Nerve Tissue Proteins--genetics
Pharmacogenetics
Pharmacogenomic Testing
Phenylenediamines--pharmacology
RNA, Messenger--metabolism
Transcriptome